Polypharmacology-based ceritinib repurposing using integrated functional proteomics
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Polypharmacology-based ceritinib repurposing using integrated functional proteomics
Authors
Keywords
-
Journal
Nature Chemical Biology
Volume 13, Issue 12, Pages 1222-1231
Publisher
Springer Nature
Online
2017-10-09
DOI
10.1038/nchembio.2489
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Discovery of Clinical Candidate CEP-37440, a Selective Inhibitor of Focal Adhesion Kinase (FAK) and Anaplastic Lymphoma Kinase (ALK)
- (2016) Gregory R. Ott et al. JOURNAL OF MEDICINAL CHEMISTRY
- APOSTL: An Interactive Galaxy Pipeline for Reproducible Analysis of Affinity Proteomics Data
- (2016) Brent M. Kuenzi et al. JOURNAL OF PROTEOME RESEARCH
- Chemoproteomics Reveals Novel Protein and Lipid Kinase Targets of Clinical CDK4/6 Inhibitors in Lung Cancer
- (2015) Natalia J. Sumi et al. ACS Chemical Biology
- Fragment-Based Discovery of a Dual pan-RET/VEGFR2 Kinase Inhibitor Optimized for Single-Agent Polypharmacology
- (2015) Brendan Frett et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Kinome-wide Decoding of Network-Attacking Mutations Rewiring Cancer Signaling
- (2015) Pau Creixell et al. CELL
- Phase I Study of Ceritinib (LDK378) in Japanese Patients with Advanced, Anaplastic Lymphoma Kinase-Rearranged Non–Small-Cell Lung Cancer or Other Tumors
- (2015) Makoto Nishio et al. Journal of Thoracic Oncology
- NDEx, the Network Data Exchange
- (2015) Dexter Pratt et al. Cell Systems
- Dose-Response Analysis Using R
- (2015) Christian Ritz et al. PLoS One
- Ceritinib in ALK-Rearranged Non–Small-Cell Lung Cancer
- (2014) Alice T. Shaw et al. NEW ENGLAND JOURNAL OF MEDICINE
- STRING v10: protein–protein interaction networks, integrated over the tree of life
- (2014) Damian Szklarczyk et al. NUCLEIC ACIDS RESEARCH
- Targeting ribosomal S6 kinases/Y-box binding protein-1 signaling improves cellular sensitivity to taxane in prostate cancer
- (2014) Masaki Shiota et al. PROSTATE
- The ALK Inhibitor Ceritinib Overcomes Crizotinib Resistance in Non-Small Cell Lung Cancer
- (2014) L. Friboulet et al. Cancer Discovery
- GSK3 Alpha and Beta Are New Functionally Relevant Targets of Tivantinib in Lung Cancer Cells
- (2013) Lily L. Remsing Rix et al. ACS Chemical Biology
- Iterative rank-order normalization of gene expression microarray data
- (2013) Eric A Welsh et al. BMC BIOINFORMATICS
- Synthesis, Structure–Activity Relationships, and in Vivo Efficacy of the Novel Potent and Selective Anaplastic Lymphoma Kinase (ALK) Inhibitor 5-Chloro-N2-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)-N4-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamine (LDK378) Currently in Phase 1 and Phase 2 Clinical Trials
- (2013) Thomas H. Marsilje et al. JOURNAL OF MEDICINAL CHEMISTRY
- Role of Focal Adhesion Kinase in Regulating YB–1–Mediated Paclitaxel Resistance in Ovarian Cancer
- (2013) Yu Kang et al. JNCI-Journal of the National Cancer Institute
- RHOA-FAK Is a Required Signaling Axis for the Maintenance of KRAS-Driven Lung Adenocarcinomas
- (2013) Georgia Konstantinidou et al. Cancer Discovery
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
- (2012) Jordi Barretina et al. NATURE
- clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters
- (2012) Guangchuang Yu et al. OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY
- Regulation and function of the RSK family of protein kinases
- (2011) Yves Romeo et al. BIOCHEMICAL JOURNAL
- Comprehensive analysis of kinase inhibitor selectivity
- (2011) Mindy I Davis et al. NATURE BIOTECHNOLOGY
- Global Phosphoproteomics Reveals Crosstalk Between Bcr-Abl and Negative Feedback Mechanisms Controlling Src Signaling
- (2011) L. Rubbi et al. Science Signaling
- Network-Based Tools for the Identification of Novel Drug Targets
- (2011) I. J. Farkas et al. Science Signaling
- Skyline: an open source document editor for creating and analyzing targeted proteomics experiments
- (2010) Brendan MacLean et al. BIOINFORMATICS
- Recovery of phospho-ERK activity allows melanoma cells to escape from BRAF inhibitor therapy
- (2010) K H T Paraiso et al. BRITISH JOURNAL OF CANCER
- Discovery of CP-690,550: A Potent and Selective Janus Kinase (JAK) Inhibitor for the Treatment of Autoimmune Diseases and Organ Transplant Rejection
- (2010) Mark E. Flanagan et al. JOURNAL OF MEDICINAL CHEMISTRY
- Network medicine: a network-based approach to human disease
- (2010) Albert-László Barabási et al. NATURE REVIEWS GENETICS
- Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
- (2010) Eunice L. Kwak et al. NEW ENGLAND JOURNAL OF MEDICINE
- Focal adhesion kinase (FAK) activates and stabilizes IGF-1 receptor
- (2009) Sandra Andersson et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- GSK1838705A inhibits the insulin-like growth factor-1 receptor and anaplastic lymphoma kinase and shows antitumor activity in experimental models of human cancers
- (2009) P. Sabbatini et al. MOLECULAR CANCER THERAPEUTICS
- A practical guide to the MaxQuant computational platform for SILAC-based quantitative proteomics
- (2009) Jürgen Cox et al. Nature Protocols
- Identifying the proteins to which small-molecule probes and drugs bind in cells
- (2009) S.-E. Ong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Fast unfolding of communities in large networks
- (2008) Vincent D Blondel et al. JOURNAL OF STATISTICAL MECHANICS-THEORY AND EXPERIMENT
- MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification
- (2008) Jürgen Cox et al. NATURE BIOTECHNOLOGY
- Network pharmacology: the next paradigm in drug discovery
- (2008) Andrew L Hopkins Nature Chemical Biology
- Molecular characterization of human Argonaute-containing ribonucleoprotein complexes and their bound target mRNAs
- (2008) M. Landthaler et al. RNA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started